Facial Volume Deficit
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants (NCT05818709) | AbbVie | 2023-06-14 |
Track Facial Volume Deficit automatically
Every clearance here is in the API, with alerts when new ones post.